Hjem › Kreft (alle typer) › Washington › Seattle
Kliniske studier for Kreft (alle typer) i Seattle, WA
49 studier for Kreft (alle typer) søker deltakere på steder i og rundt Seattle (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- Fred Hutchinson Cancer Center. /ID# 277939, Seattle
Registry Study for Radiation Therapy Outcomes
RekruttererObservasjonsstudie
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- Fred Hutchinson Cancer Center, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruttererFase 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RekruttererFase 1
- Swedish Cancer Institute, Seattle
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Rekrutterer
- Seattle Children's Hospital, Seattle
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
RekruttererFase 3
- Fred Hutchinson Cancer Center ( Site 0106), Seattle
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Swedish Cancer Institute, Seattle
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
RekruttererObservasjonsstudie
- Fred Hutchinson, Seattle
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- Seattle Neuropsychiatric Treatment Center, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RekruttererFase 1
- Investigational Site Number: 400, Seattle
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RekruttererObservasjonsstudie
- University of Washington, Seattle
Prostate Active Surveillance Study
RekruttererObservasjonsstudie
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Seattle Children's Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekruttererFase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
RekruttererFrivillige helsepersonell ønskes velkommen
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RekruttererFase 2
- Seattle Children's Hospital Research Foundation, Seattle
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- og 4 flere
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
RekruttererFase 2
- Seattle Children's Hospital, Seattle
Resilience Mobile App for Teens and Young Adults With Cancer
Rekrutterer
- Seattle Children's Hospital, Seattle
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Fred Hutchinson Cancer Center. /ID# 267940, Seattle
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruttererFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekruttererFase 1
- GSK Investigational Site, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Childhood Cancer Survivor Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Seattle Children's Hospital, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- University of Washington Medical Center /ID# 275866, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- University of Washington Medical Center, Seattle
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Fred Hutchinson Cancer Centre, Seattle
Suprachoroidal Administration in Subjects With Metastases to the Choroid
RekruttererFase 2
- University of Washington, Seattle
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RekruttererFase 2
- Seattle Children's Hospital, Seattle
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
RekruttererObservasjonsstudie
- Seattle Children's Hospital, Seattle
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
RekruttererFase 2
- Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Seattle
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
RekruttererFase 1
- Fred Hutch Cancer Center, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
RekruttererObservasjonsstudie
- The Swedish Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
RekruttererObservasjonsstudie
- Swedish Cancer Institute, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
RekruttererObservasjonsstudie
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Crowd Sourcing Platform for Patients With Cancer
RekruttererObservasjonsstudie
- All4Cure, Seattle
AIMS Cancer Outcomes Study
RekruttererObservasjonsstudie
- AIMS Institute, Seattle
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY110 studier
- Boston, MA86 studier
- Los Angeles, CA73 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Durham, NC58 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Arlington, VA48 studier
- St. Louis, MO46 studier
Andre studier i Seattle
- Ikke-småcellet lungekreft53 studier
- Prostatakreft42 studier
- Akut myelogen leukemi40 studier
- Brystkreft39 studier
- Metastatisk kreft39 studier
- Kolorektal kreft34 studier
- Lungekreft33 studier
- Eggstokkreft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukemi21 studier
- Blærekreft21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.